Larotrectinib

ATC L01EX12 · 7 markets · 26 records

Larotrectinib 7 markets · 26 records Forms

US 7 records · 3 strengths

GB 4 records · 3 strengths

AU 4 records · 4 strengths

Records without a stated strength · 1 VITRAKVI

ES 3 records · 3 strengths

TW 3 records · 3 strengths

HK 3 records · 1 strengths

    Records without a stated strength · 1 VITRAKVI、Vitrakvi 20mg/ml oral solution

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      Records without a stated strength · 1 VITRAKVI

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.